Cargando…
Ability of the COPD Assessment Test to evaluate the lung‐specific quality of life in systemic sclerosis‐associated interstitial lung disease
INTRODUCTION: The COPD Assessment Test (CAT) is utilised to evaluate the treatment outcome regarding the health status in idiopathic interstitial pneumonia (IIP). However, the ability of the CAT to evaluate the lung‐specific quality of life in systemic sclerosis‐associated interstitial lung disease...
Autores principales: | Mugii, Naoki, Someya, Fujiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318680/ https://www.ncbi.nlm.nih.gov/pubmed/32045097 http://dx.doi.org/10.1111/crj.13162 |
Ejemplares similares
-
The COPD Assessment Test as a Prognostic Marker in Interstitial Lung Disease
por: Someya, Fujiko, et al.
Publicado: (2016) -
Limitations to the 6-Minute Walk Test in Dermatomyositis with Interstitial Lung Disease in Comparison with Idiopathic Interstitial Pneumonia
por: Someya, Fujiko, et al.
Publicado: (2013) -
Reduced Hypoxia Risk in a Systemic Sclerosis Patient with Interstitial Lung Disease after Long-Term Pulmonary Rehabilitation
por: Mugii, Naoki, et al.
Publicado: (2011) -
Exercise capacity in relation to autoantibodies in systemic sclerosis patients
por: Someya, Fujiko, et al.
Publicado: (2012) -
Cardiac hemodynamic response to the 6-minute walk test in young adults and the elderly
por: Someya, Fujiko, et al.
Publicado: (2015)